Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00151177
Other study ID # IMF-DZ-110413
Secondary ID NHSi2005-iCPAPAP
Status Completed
Phase Phase 1/Phase 2
First received September 7, 2005
Last updated November 23, 2010
Start date April 2005
Est. completion date April 2008

Study information

Verified date April 2008
Source University Hospital Muenster
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

More than half of all stroke patients have sleep apneas in the acute phase after stroke. Sleep apneas may be associated with higher degrees of disability three months after stroke due to numerous factors associated with sleep apneas such as persistent hypertension, cardiac arrhythmias, and clotting disorders.

Non-invasive CPAP (continuous positive airway pressure)-therapy may reverse a number of these effects very shortly after initiation. The aim of the study is to test the feasibility of early non-invasive CPAP treatment starting in the first night after stroke onset, and to test its efficacy in a randomized clinical trial.

50 patients with acute ischemic stroke will be enrolled and randomly assigned to standard care PLUS CPAP treatment or standard care only. All patients randomized to the intervention group will receive CPAP therapy for the first three nights after stroke. In the fourth night, a cardiorespiratory polygraphy will be performed in patients and controls. Patients assigned to the intervention group with a respiratory distress index > 10/h will be treated further on. On admission, day 4, and day 10 after stroke, diffusion weighted MRI imaging will be performed to determine the size of the infarction. The NIHSS score will be used to assess clinical short-term outcome on day 4 and day 10. After three months, the outcome will be determined using the modified Rankin scale.

As CPAP therapy may be more laborious for the provider, the additional work-load will be documented using pre-specified scales.

Primary hypothesis of the study is, that CPAP therapy is feasible in acute stroke patients and that the additional work load will not outweigh the benefits.

Secondary hypothesis is that patients assigned to the treatment group have smaller infarctions on MRI and less neurological deficits at 3 months after stroke.

Patients entering the study will be investigated by transcranial Doppler ultrasound in case they have sufficient temporal bone windows for insonation and no stenosis or occlusions of major brain supplying arteries by the time of investigation that disturb the intracerebral blood flow.

All intracranial arteries will be assessed before treatment, after treatment and on day 8 after the insult.

Screen shots will be taken and will be analysed by dynamic vascular ultrasound (DVA), a new software algorithm developed by NHSi, to investigate microcirculatory information from the flow spectra of the major intracranial arteries.

The data from this post-hoc analysis are compared with the data of the polysomnography and with treatment.

Primary hypothesis in this substudy is that DVA reliably identifies patients with sleep apnea on days one and four after stroke. Secondary hypothesis is that DVA can distinguish between treated patients and controls.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date April 2008
Est. primary completion date January 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion criteria:

- AGE 18-85 years,

- NIH-SS 2-20 points,

- NIH-SS subitem 1a <=1.

Exclusion criteria:

- Modified Rankin Scale Score >=2 on admission

- primary intubation,

- Congestive heart failure (NYHA >=3),

- respiratory insufficiency

- recurrent vomiting

- absence of gag reflex,

- participation in another RCT

for the ultrasound sub-study

- absence of temporal bone window for insonation

- stenosis or occlusion of major brain supplying arteries interfering with normal blood flow

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
non-invasive continuous positive airway pressure ventilation

CPAP-treatment
night time CPAP-mask ventilation

Locations

Country Name City State
Germany University_Hospital_Muenster Muenster

Sponsors (3)

Lead Sponsor Collaborator
University Hospital Muenster New Health Sciences, Inc., Rubel GmbH, Heiligenhaus, Germany

Country where clinical trial is conducted

Germany, 

References & Publications (3)

Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke. 1997 Sep;28(9):1765-72. — View Citation

Iranzo A, Santamaría J, Berenguer J, Sánchez M, Chamorro A. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology. 2002 Mar 26;58(6):911-6. — View Citation

Turkington PM, Bamford J, Wanklyn P, Elliott MW. Prevalence and predictors of upper airway obstruction in the first 24 hours after acute stroke. Stroke. 2002 Aug;33(8):2037-42. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Primary endpoint is to test the feasibility of early non-invasive CPAP ventilation in acute stroke patients
Secondary Size of brain infarction on diffusion weighted MRI imaging at day 10 after symptom onset
Secondary Disability measured by the modified Rankin scale after three months
See also
  Status Clinical Trial Phase
Completed NCT01977456 - Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR) Phase 2
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT01561677 - Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke. N/A
Terminated NCT00141011 - Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Phase 3
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT01934725 - Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
Terminated NCT01059149 - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) Phase 2
Recruiting NCT05068349 - For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide. Phase 4
Completed NCT05086874 - Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients
Completed NCT00126516 - Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline Phase 4
Completed NCT02389894 - Neuroprotection in Patients Undergoing Aortic Valve Replacement N/A
Terminated NCT00300196 - ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Phase 3
Completed NCT00871715 - Arm Rehabilitation Study After Stroke N/A
Completed NCT04265664 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke N/A
Completed NCT04043559 - Cortical Cerebellar Infarctions Associated With Patent Foramen Ovale in Young Stroke Patients
Completed NCT00894803 - Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke Phase 2
Active, not recruiting NCT00657969 - Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections N/A
Completed NCT05169450 - Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke N/A